Why is cerebrospinal fluid (CSF) protein increased in Guillain‑Barré syndrome?

Why CSF Protein is Increased in Guillain-Barré Syndrome

CSF protein elevation in Guillain-Barré syndrome occurs due to blood-CSF barrier (B-CSFB) dysfunction caused by inflammatory damage to nerve roots, which allows serum proteins—particularly albumin—to leak into the cerebrospinal fluid while the blood-brain barrier remains intact, preventing cellular infiltration. 1

Pathophysiological Mechanism

The characteristic finding of albuminocytologic dissociation (elevated protein with normal cell count) reflects the unique anatomical vulnerability of nerve roots in GBS 2:

• Nerve root inflammation occurs at the junction where peripheral nerves enter the spinal canal
• The blood-nerve barrier at this location becomes disrupted by the immune-mediated inflammatory process
• Large serum proteins (mainly albumin) leak through the damaged barrier into CSF
• The blood-brain barrier itself remains intact, preventing white blood cells from entering the CSF
• This explains why protein rises while cell count stays normal (<5 cells/μL in 83% of patients) 3

Clinical Correlation with Disease Severity

Higher CSF protein levels directly correlate with more severe disease and worse short-term outcomes 3:

• Patients with elevated CSF protein are less likely to run at week 2 (OR 0.42) and week 4 (OR 0.44)
• CSF protein elevation associates with proximal or global muscle weakness patterns
• The degree of protein elevation correlates with the number of demyelinating abnormalities on nerve conduction studies 4
• Severely ill patients (Hughes Grade IV) have mean CSF protein of 217 mg/dl versus 99.86 mg/dl in mild cases 5

Time-Dependent Evolution

CSF protein elevation is time-dependent and may be normal early in the disease course 3, 6:

• Only 57% show albuminocytologic dissociation within 4 days of symptom onset
• This increases to 84% after 4 days from onset
• Peak elevation typically occurs around 10±2 days from disease onset 5
• A normal CSF protein in the first few days does NOT exclude GBS

Clinical Pitfall

Lumbar puncture performed too early (first 3-4 days) may show normal protein, leading to false reassurance. If clinical suspicion remains high, repeat lumbar puncture after 1 week may demonstrate the classic albuminocytologic dissociation.

Subtype Variations

CSF protein elevation varies by GBS subtype 3, 5:

• Demyelinating (AIDP): Highest elevation (mean 245 mg/dl)
• Axonal motor (AMAN): Moderate elevation (mean 153 mg/dl)
• Axonal motor-sensory (AMSAN): Moderate elevation (mean 165 mg/dl)
• Miller Fisher syndrome: Often lower protein levels
• Distal predominant weakness: Lower protein levels

Prognostic Implications

The B-CSFB dysfunction response pattern has prognostic value 1:

• Persistent or increasing protein elevation during follow-up (around day 15) suggests active regeneration
• Failure to show elevated protein response during follow-up was associated with lethal outcomes
• This suggests B-CSFB dysfunction may serve a "protective" effect during nerve regeneration

Cell Count Considerations

While protein is elevated, cell count remains the critical distinguishing feature 3:

• 83% have <5 cells/μL (truly acellular)
• 16% have 5-49 cells/μL (mild pleocytosis, still compatible with GBS)
• Only 1% have ≥50 cells/μL (should prompt thorough exclusion of alternative diagnoses like Lyme disease, HIV, or malignancy)

Any CSF pleocytosis ≥50 cells/μL should trigger aggressive investigation for alternative diagnoses, though mild elevation up to 49 cells/μL can occur in GBS after excluding other causes 3.